Passage Bio Inc Financial Flexibility Index
Passage Bio Inc financial flexibility index. Passage Bio Inc (PASG) has a Financial Flexibility Index of -0.44x as of June 2026. Free cash flow of $-9.18 Million (operating CF $-9.18 Million minus capex $0.00) represents 0% of total liabilities ($20.72 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Passage Bio Inc (2018–2025)
Financial flexibility index of Passage Bio Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Passage Bio Inc across 8 annual periods. Explore Passage Bio Inc (PASG) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Passage Bio Inc Financial Flexibility Index by Year (2018–2025)
Passage Bio Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Passage Bio Inc. For the full cash flow conversion analysis, see Passage Bio Inc operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.72x | $-31.51 Million | $-31.51 Million | $43.53 Million | ▲ +37.8% |
| 2024 | -1.16x | $-47.92 Million | $-47.96 Million | $41.15 Million | ▲ +41.5% |
| 2023 | -1.99x | $-78.12 Million | $-78.26 Million | $39.26 Million | ▲ +25.7% |
| 2022 | -2.68x | $-112.94 Million | $-118.21 Million | $42.18 Million | ▲ +3.7% |
| 2021 | -2.78x | $-101.24 Million | $-126.88 Million | $36.42 Million | ▲ +17.9% |
| 2020 | -3.39x | $-78.87 Million | $-80.52 Million | $23.29 Million | ▲ +62.2% |
| 2019 | -8.97x | $-38.20 Million | $-39.90 Million | $4.26 Million | ▼ -2453.3% |
| 2018 | -0.35x | $-16.02 Million | $-18.57 Million | $45.63 Million | — |